Sturge-Weber syndrome (SWS) is a rare, congenital but sporadic disease characterized by a facial port-wine birthmark, choroidal and leptomeningeal vascular malformations, epilepsy, stroke-like episodes, headache, and cognitive impairment. The disease is characterized by ongoing vascular overgrowth;histopathological studies of SWS lesion tissue show abnormal expression of vascular phenotypes and angiogenic factors. Angiogenic factors correlate with clinical severity suggesting that vascular remodeling is important in SWS. We hypothesize that vascular remodeling is ongoing in SWS, is central to the clinical progression, and is related to the recently discovered pathogenic somatic mutation in GNAQ. The causative somatic mutation for SWS is an activating mutation in the GNAQ gene, a guanine nucleotide binding protein essential in transmitting signals from G-protein coupled receptors (GPCRs), many of which are essential to vascular development and function. With this new knowledge, we will investigate our central hypotheses and prepare for treatment trials with clinical, biochemical, and molecular analyses. In Project 2, our database will continue to capture SWS patients across the nation as they are seen at Sturge-Weber Foundation (SWF) Centers of Excellence. This database is the first national SWS database with longitudinal clinical data and this effort has integrated seven clinical research centers. We now propose to take the next steps in multi-centered clinical research and engage in longitudinal multi-centered clinical research that will quantify vascular remodeling in subjects with SWS, develop new biomarkers, and propose a safety drug study as a pilot project. We will also build upon the remarkable success of our first round of funding, the discovery of the somatic mosaic mutation in GNAQ that causes SWS, and determine the impact of this genetic defect upon downstream proteins and pathways in SWS skin and brain tissue. The illumination of the molecular genetic pathways of SWS will suggest new avenues for future development of therapy.

Public Health Relevance

Sturge-Weber Syndrome (SWS) is a rare, congenital but sporadic disease characterized by ongoing vascular overgrowth. We hypothesize that vascular remodeling is ongoing in SWS and is related to to the recently discovered pathogenic somatic mutation in GNAQ. With this new knowledge, we will investigate our central hypotheses and prepare for treatment trials.

Agency
National Institute of Health (NIH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54NS065705-06
Application #
8913452
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Moy, Claudia S
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Choquet, Hélène; Nelson, Jeffrey; Pawlikowska, Ludmila et al. (2014) Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis 37:57-63
Reidy, Teressa Garcia; Suskauer, Stacy J; Bachur, Cathy D et al. (2014) Preliminary reliability and validity of a battery for assessing functional skills in children with Sturge-Weber syndrome. Childs Nerv Syst 30:2027-36
Cheng, Kyle H Y; Mariampillai, Adrian; Lee, Kenneth K C et al. (2014) Histogram flow mapping with optical coherence tomography for in vivo skin angiography of hereditary hemorrhagic telangiectasia. J Biomed Opt 19:086015
Lance, Eboni I; Sreenivasan, Aditya K; Zabel, T Andrew et al. (2013) Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes. J Child Neurol 28:213-8
Sreenivasan, Aditya K; Bachur, Catherine D; Lanier, Kira E et al. (2013) Urine vascular biomarkers in Sturge-Weber syndrome. Vasc Med 18:122-8
Lopez, Jonathan; Yeom, Kristen W; Comi, Anne et al. (2013) Case report of subdural hematoma in a patient with Sturge-Weber syndrome and literature review: questions and implications for therapy. J Child Neurol 28:672-5
Siddique, Laila; Sreenivasan, Aditya; Comi, Anne M et al. (2013) Importance of utilizing a sensitive free thyroxine assay in Sturge-Weber syndrome. J Child Neurol 28:269-74
Arora, Karun S; Quigley, Harry A; Comi, Anne M et al. (2013) Increased choroidal thickness in patients with Sturge-Weber syndrome. JAMA Ophthalmol 131:1216-9
Shirley, Matthew D; Tang, Hao; Gallione, Carol J et al. (2013) Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971-9
Lo, Warren; Marchuk, Douglas A; Ball, Karen L et al. (2012) Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement. Dev Med Child Neurol 54:214-23

Showing the most recent 10 out of 11 publications